(Q40640666)

22 September 2017

title

c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571. (English)

1 reference

22 September 2017

1 reference

1

1 reference

22 September 2017

Vincenzo Cesi

2

1 reference

22 September 2017

Maria Rita Nicotra

3

1 reference

22 September 2017

Heather P McDowell

4

1 reference

22 September 2017

Alberto Donfrancesco

5

1 reference

22 September 2017

Olga Mannarino

6

1 reference

22 September 2017

Pier Giorgio Natali

7

1 reference

22 September 2017

Giuseppe Raschellà

8

1 reference

22 September 2017

Carlo Dominici

9

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

International Journal of Cancer

22 September 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

22 September 2017

volume

106

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

147-152

1 reference

Successful management of low-stage neuroblastoma without adjuvant therapies: a comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution

22 September 2017

cites work

1 reference

Induction chemotherapy in metastatic neuroblastoma--does dose influence response? A critical review of published data standards, options and recommendations (SOR) project of the National Federation of French Cancer Centres (FNCLCC).

21 January 2018

1 reference

Smart drugs: tyrosine kinase inhibitors in cancer therapy

21 January 2018

1 reference

STI571: a paradigm of new agents for cancer therapeutics

21 January 2018

1 reference

Association of near-diploid DNA content and N-myc amplification in neuroblastomas

21 January 2018

1 reference

C-kit expression in pediatric solid tumors: a comparative immunohistochemical study

21 January 2018

1 reference

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

21 January 2018

1 reference

Establishment and characterization of a human neuroblastoma cell line

21 January 2018

1 reference

Bi-modal differentiation pattern in a new human neuroblastoma cell line in vitro

21 January 2018

1 reference

N-myc amplification at chromosome band 1p32 in neuroblastoma cells as investigated by in situ hybridization.

21 January 2018

1 reference

Internalization and degradation of monoclonal antibody chCE7 by human neuroblastoma cells

21 January 2018

1 reference

Retinoic acid receptor gamma1 (RARgamma1) levels control RARbeta2 expression in SK-N-BE2(c) neuroblastoma cells and regulate a differentiation-apoptosis switch.

21 January 2018

1 reference

Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms

21 January 2018

1 reference

Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis

21 January 2018

1 reference

A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin

21 January 2018

1 reference

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

21 January 2018

1 reference

Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells.

21 January 2018

1 reference

Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies

21 January 2018

1 reference

Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction

21 January 2018

1 reference

Disabling Abl-perspectives on Abl kinase regulation and cancer therapeutics

21 January 2018

1 reference

Perspectives on the development of a molecularly targeted agent

21 January 2018

1 reference

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

21 January 2018

1 reference

Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor.

21 January 2018

1 reference

Expression of the c-Kit receptor and its ligand SCF in non-small-cell lung carcinomas.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.11187

1 reference

22 September 2017

1 reference